Awards & Recognitions
Ghana Health Service
Ghana Health Service, 2022
The NMIMR was awarded the Excellence in Malaria Research as recognition by the Ghana Health Service for its work in the eliminating malaria in the country though exceptional research, at a special event in Accra on 6th May 2022
UGBS Business Excellence Award, 2022
12th July, 2022 the Institute received the UGBS Business Excellence Award in recognition of the efforts in the fight against the COVID-19 disease.
The West African Clinical Alliance
The West African Clinical Alliance Awards, 2021
The Noguchi Memorial Institute for Medical Research received an award for ‘Leader in COVID-19 Research Delivery’ at the West Africa Clinical Alliance Awards 2021. The award was in recognition of the Institute’s service to the country and the African region after the COVID-19 pandemic hit the world in 2019.
Millennium Excellence Foundation
Millennium Excellence Foundation, 2021
Association of Ghana Industries
AGI Award 2020
The Institute was given an honorary award at the 9th Association of Ghana Industries (AGI) and Quality Awards 2020 on November 13, 2020. This comes after the AGI Awards Technical Committee narrowed down the list of nominees and evaluated them afterward in honor of the Institute’s valiant battle against the COVID-19 outbreak. The institute administrator, Mr. Theodore Ahuno, accepted the honor. He made a special dedication of the prize to all the employees who have worked and are still working hard to stop the pandemic.
EMY Africa Foundation
EMY Africa Awards
EMY Africa Awards: Exceptional Contribution towards the fight against COVID-19
JICA President Award
JICA President Award : In recognition of outstanding contributions to the work of Japan International Cooperation Agency (JICA) and to enhance the social and Economic Development.
Africa Knowledge Transfer Partnership Award
1ST Ghana Premier Business & Finance Excellence
Special Gold Award
Jubilee Business and Financial Services
Millennium Excellence Foundation
Millennium Excellence Award
Navrongo Health Research Centre
Plaque of Honour
Ghana Biomedical Convention
Ghana Field Epidemiology and Laboratory Training Program (GFELTP)
Presidential award of Honour for Distinguished Service
NMIMR receives a ‘Presidential award of Honour for Distinguished Service’ during the COVID-19 pandemic - 2023
The Institute, on Tuesday, March 14, 2023 received a Presidential award of ‘Honour for Distinguished Service’ at the National Honours and Awards 2023 held at the Accra International Conference Centre (AICC).
The award was to recognize the Institute’s good works and distinguished output, and the key role played both locally and internationally in the management and control of the novel coronavirus pandemic.
Professor William Ampofo
MTN Hero of Change, Health Sector, 2022
Dr. Irene Owusu Donkor
Young Investigator award, 2022
Dr. Jewelna Akorli
Senior Category of the 2nd PAMCA Women in Vector Control (WIVC) Excellence Award, 2022
Dr. Prince Asare
Vice Chancellor's Award, 2021
Prof. Irene Ayi
Supervisor for Best Phd Thesis, 2017
At the 12th session of the 49th Congregation of the University of Cape Coast on March 25, 2017, Prof. Ayi received an award in recognition of her supervisory role for Dr. Emmanuel K. Abu’s PhD thesis. Dr. Abu was the Congregation’s valedictorian. His research was conducted at the Biomedical and Forensic Sciences Department, University of Cape Coast, and the topic of his thesis was “Toxoplasmosis and its connection with IFN- +874 Polymorphism among coastal and inland farming groups in Central Region, Ghana.”
Prof. Kwadwo Asamoah Kusi
National Youth Achievers Awards, 2012
Prof. Kwadwo Asamoah Kusi of the Immunology Department of NMIMR is the recipient of a science achievement gold award at the 1st National Youth Achievers Awards (NYAA), held at the Accra International Conference Centre on 25th October 2012. The awards scheme was under the auspices of His Excellency John Dramani Mahama, Former President of the Republic of Ghana for youth (15 – 35 years) who are considered to have made a significant contribution to their field of endeavor.
The programme was organized by Charter House Productions with sponsorship from RLG Communications Ghana Ltd.
Prof. Kusi’s award was based on his PhD work on the development of malaria vaccine candidate antigens. He worked as part of a team that undertook the development and pre-clinical testing of three Diversity-covering (DiCo) AMA1 proteins as malaria vaccine candidate antigens at the biomedical Primate Research Centre in Rijswijk, the Netherlands. His work focused on the assessment of humoral immune responses to polymorphic variants of AMA1 and the formulation of multi-allele AMA1 antigens with adjuvants as vaccines. His contribution to this process resulted in five peer-reviewed publications.
The DiCo vaccine candidate, which is a mixture of the three DiCo antigens, has successfully undergone GMP production and is expected to undergo toxicology, clinical safety and immunogenicity assessment in a non-endemic population soon. These activities are with support from the European Vaccine Institute (http://www.euvaccine.eu/portfolio/project-index/ama1-dico and http://www.euvaccine.eu/node/651#KAK).
Prof. Kusi is currently working on the development of malaria transmission estimation tools at the Noguchi Memorial Institute together with scientists from the Naval Medical Research Centre of the US Military Malaria Vaccine Program.
Award received: 2012 National Youth Achievers Gold Award (Science category)
Dr. James Brandful
Vice Chancellor’s Award, 2012
The Vice Chancellor’s Academic Prize was awarded to Dr. James A.M Brandful for Outstanding Doctoral Dissertation in Science for 2012 Congregation, Great Hall, May 4th, 2012. The award was based on his doctoral thesis leading to the degree of Ph.D. in Medical Microbiology obtained in June 2009.
A short summary of PhD thesis work
This was titled ‘Genotypic and Phenotypic Characterization of HIV Type 1 in Parts of Ghana’. The study examined 40 samples collected in 2002/3 from HIV-1 AIDS disease and asymptomatic patients prior to antiretroviral therapy (ART). The focus was on under-investigated areas of Ghana, covering the middle and northern belts. Genetic diversity and the potential for the emergence of resistance to antiretroviral drugs in this group and therefore implications for ART were examined.
Main observations included the following: A diversity of non-subtype B HIV-1 strains was prevalent. The simultaneous circulation of these diverse variants, even in a small sample size, suggested that changes in the genotypic profile of HIV-1 in Ghana will continue. Majority of the isolates were non-syncytium inducing R5 viruses even in late disease stage. Syncytium-inducing or X4 strains also co-circulated, but were rare. Genetic sequence data indicated that antagonists to R5 viruses could therefore be extremely effective theoretically as antiviral agents for HIV-1 strains from Ghana, along with two broad neutralizing monoclonal antibodies, namely 2F5 and 4E10.
The transmission of drug resistant (DR) HIV-1 strains through CRF02_AG, even before the initiation of ART was probable. PR V11I mutation, among others, was observed in patients with CRF02_AG and CRF06_cpx infections, recombinants chiefly now responsible for AIDS in Ghana. The use of darunavir (DRV) and fosamprenavir (FPV), not currently included in the ART regimen prescribed in Ghana had to be avoided in such patients.
The identification of DR-related mutations in drug-inexperienced patients constituted important new information that is relevant for ART in Ghana. Also, the study had far-reaching implications for possible new clinical interventions from phenotypic aspects of the work.
The diverse genetic profile of HIV-1 in Ghana has to be continuously monitored.